ProCE Banner Series

Advances in Bispecific Antibodies in NHL: Practical Strategies for Oncology Pharmacists to Improve Patient Care

Join us online for this interactive webinar designed for oncology pharmacists to explore the latest advancements in managing patients with non-Hodgkin lymphoma using bispecific antibodies.

  ACPE-P
Who Should Attend

This activity has been designed to meet the educational needs of oncology pharmacists and other healthcare professionals caring for patients with lymphomas. 

All Events

Advances in Bispecific Antibodies in NHL: Practical Strategies for Oncology Pharmacists to Improve Patient Care

Upcoming Events

May

14

2025

6:00 PM - 7:00 PM Eastern Time (ET)

Virtual

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge and competence of learners in effort to optimize treatment for patients with B-cell Lymphoma.

Target Audience
This activity has been designed to meet the educational needs of oncology pharmacists and other healthcare professionals caring for patients with lymphomas. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Explain the mechanism of action of novel and investigational bispecific antibodies for treating non-Hodgkin lymphomas.

  • Interpret clinical trial data, guideline recommendations, and patient-specific factors to aid the refinement of individualized treatment plans, including therapy sequencing, for the use of bispecific antibodies in patients with NHL.

  • Formulate recommendations to mitigate TRAEs associated with bispecific antibodies, using best practices and patient counseling to emphasize the importance of reporting and addressing toxicities to improve adherence to therapy, patient quality of life, and clinical outcomes.

Accreditation

CE Accreditation

Pharmacists

This activity is jointly provided by ProCE, LLC and Clinical Care Options, LLC. ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-25-009-L01-P has been assigned to this live application-based activity (initial release date 5/14/2025). This activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. This activity is provided at no cost to participants. Participants must complete the  activity evaluation within 30 days of the activity to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles. 

Disclosure
ProCE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by ProCE, LLC In partnership with Clinical Care Options, LLC.

ProCE, LLC

Supporters

Supported by an educational grant from Genentech, a member of the Roche Group.

Genentech, a member of the Roche Group

Partners

Clinical Care Options, LLC

ProCE Banner

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191